Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 4/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL169321 | 1.00 | SLC7A5 (0.55) | SLC7A5CA2CAMK2AESR1ESR2 | |
| Methane SCHEMBL17267562 | 0.98 | SLC7A5 (0.53) | SLC7A5CA2CAMK2AESR1ESR2 | |
| SCHEMBL10938101 | 0.91 | SLC7A5 (0.46) | SLC7A5ESR1ESR2 | |
| SCHEMBL836728 | 0.91 | SLC7A5 (0.46) | SLC7A5ESR1ESR2 | |
| SCHEMBL23610314 | 0.86 | SLC7A5 (0.51) | SLC7A5CA2CAMK2AESR1ESR2 | |
| SCHEMBL11053246 | 0.86 | SLC7A5 (0.51) | SLC7A5CA2CAMK2AESR1ESR2 | |
| SCHEMBL22615037 | 0.86 | SLC7A5 (0.51) | SLC7A5CA2CAMK2AESR1ESR2 | |
| SCHEMBL11053244 | 0.86 | SLC7A5 (0.51) | SLC7A5CA2CAMK2AESR1ESR2 | |
| SCHEMBL31723949 | 0.85 | CYP1A2 (0.55) | SLC7A5FOLH1 | |
| SCHEMBL2542276 | 0.83 | SLC7A5 (0.56) | SLC7A5CA2CAMK2AESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12546788-B2 | Methods for differentiating destructive thyroiditis from other pathological conditions | ASKA PHARMACEUTICAL CO., LTD. (JP) | 2026-02-10 | — | — | US | claimed |
| US-12540403-B2 | Stable composition for catalytic deposition of silver | SWISSTO12 SA (CH) | 2026-02-03 | — | — | US | claimed |
| US-12480021-B2 | Composition for semiconductor process, method for preparing the same and method for preparing semiconductor device using the same | SK ENPULSE CO., LTD. (KR) | 2025-11-25 | — | — | US | claimed |
| US-20250345488-A1 | CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-11-13 | — | — | US | claimed |
| US-20240301558-A1 | STABLE COMPOSITION FOR CATALYTIC DEPOSITION OF SILVER | SWISSTO12 SA (CH) | 2024-09-12 | — | — | US | claimed |
| CN-116077712-B | Graphene composite microsphere, preparation method thereof, embolic material and pharmaceutical preparation | 北京石墨烯技术研究院有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-115156529-B | Silver-coated copper powder and preparation method thereof | 苏州大学 | 2024-06-28 | — | — | CN | claimed |
| CN-117554536-B | Simultaneous analysis method for 15 thyroid hormones in environmental water sample | 北京林业大学 | 2024-03-19 | — | — | CN | claimed |
| CN-117554536-A | Simultaneous analysis method for 15 thyroid hormones in environmental water sample | 北京林业大学 | 2024-02-13 | — | — | CN | claimed |
| WO-2023234809-A1 | METHOD FOR PREVENTING IODINE RADIONUCLIDE DAMAGE TO THE HUMAN OR ANIMAL BODY | АНДРЕЙЧУК, ВАСИЛИЙ ПЕТРОВИЧ | 2023-12-07 | — | — | WO | claimed |
| WO-1997046541-A2 | USE OF TRIAZINE-BASED UVAs FOR USE AS QUENCHERS IN PAPER-MAKING PROCESSES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1997-12-11 | — | — | WO | claimed |
| EP-0599908-B1 | NEW GANGLIOSIDE DERIVATIVES | FIDIA SPA (IT) | 1997-03-12 | — | — | EP | claimed |
| EP-0649325-A4 | ADMINISTRATION OF MEDICAMENTS TO POULTRY. | SANOFI ANIMAL HEALTH INC (US) | 1995-08-23 | — | — | EP | claimed |
| EP-0649325-A1 | ADMINISTRATION OF MEDICAMENTS TO POULTRY | SANOFI ANIMAL HEALTH, Inc. (US) | 1995-04-26 | — | — | EP | claimed |
| US-5350841-A | Amide derivatives of gangliocides including aminoacids or amino sulfonic acids for nervous system disorders | FIDIA S.P.A. (IT) | 1994-09-27 | — | — | US | claimed |
| EP-0599908-A1 | NEW GANGLIOSIDE DERIVATIVES. | FIDIA SPA (IT) | 1994-06-08 | — | — | EP | claimed |
| US-5311841-A | Administration of medicaments of poultry | THAXTON, J. PAUL | 1994-05-17 | — | — | US | claimed |
| WO-1994001147-A2 | ADMINISTRATION OF MEDICAMENTS TO POULTRY | SANOFI ANIMAL HEALTH, INC. (US) | 1994-01-20 | — | — | WO | claimed |
| WO-1993003049-A1 | NEW GANGLIOSIDE DERIVATIVES | FIDIA S.P.A. (IT) | 1993-02-18 | — | — | WO | claimed |
| EP-0378318-A1 | Process for synthesis of FK-506 and tricarbonyl intermediates | MERCK & CO. INC. (US) | 1990-07-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540403-B2 | Stable composition for catalytic deposition of silver | SOD1, CA3, CA1 | SLC7A5 2244/4885CA2 6/4885CAMK2A 2207/4885 |
| US-12546788-B2 | Methods for differentiating destructive thyroiditis from other pathological conditions | TPO, TSHR, TH | SLC7A5 1460/4885CA2 1208/4885CAMK2A 2071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.